Branded glatiramer acetate (Copaxone) was approved by the FDA in 1995 at a dose of 20 mg per day, injected […]
Month: January 2016
January 25, 2016 WILL GENERIC COPAXONE REDUCE THE COSTS OF TREATING MULTIPLE SCLEROSIS?
January 15, 2016 GOALS FOR MIGRAINE TREATMENT IN 2016: ZOCOR AND VITAMIN D3
This combination seems too good to be true. Fifty-seven patients with episodic migraine, meaning 14 or less attacks per month, […]
January 11, 2016 HOW MUCH VITAMIN D IS TOO MUCH FOR PERSONS WITH MULTIPLE SCLEROSIS?
Saying “persons with MS” seems clumsy, but when MS patients are asked what they want to be called, they often […]
January 8, 2016 EXTENDED DOSING OF TYSABRI MAY REDUCE PML RISK
Progressive multifocal leukoencephalopathy (PML) is the most feared serious adverse effect of use of Tysabri for relapsing MS. The medication […]
January 4, 2016 CAN OMEGA-3 SUPPLEMENTS PREVENT COGNITIVE DECLINE?
They may, but only if combined with cognitive and physical training. This is the conclusion of a 3-year study from […]
January 4, 2016 VACCINATIONS MAY REDUCE RISK OF STROKE IN CHILDREN
Some parents believe that vaccinating their children puts them at risk for numerous disorders, including autism. A new study adds […]